We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IPO

News List

Bispecific antibody builder Abpro postpones $69M IPO fiercebiotech
May 16, 2018
The early-stage biotech Abpro has postponed its $69 million IPO, according to a report from Renaissance Capital, delaying a capital infusion it hoped would support the first clinical trials of its lead product candidates over the next year
3 Biotechs Seeking $271M IPO in the New Year biospace
January 03, 2018
Individuals aren’t the only ones making New Year’s Resolutions. Three biotech companies want to start out the new year with a new start—as publicly traded companies.
Rhythm Pharma strikes a chord with oversubscribed $120M IPO fiercebiotech
October 09, 2017
Rhythm Pharmaceuticals has topped its expectations in its IPO, selling more shares—at a higher price—than expected when it announced its intention to go public a few weeks back.